Ratan Medicos Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.05 Cr
as on 16-11-2024
- Revenue 13.50%
(FY 2023)
- Profit 5.93%
(FY 2023)
- Ebitda 21.83%
(FY 2023)
- Net Worth 17.71%
(FY 2023)
- Total Assets 7.58%
(FY 2023)
About Ratan Medicos
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.05 Cr.
Ravinder Garg, Sanjay Garg, and Sonika Garg serve as directors at the Company.
- CIN/LLPIN
U24231DL2006PTC146645
- Company No.
146645
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- LocationNew Delhi, Delhi
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ratan Medicos?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravinder Garg  | Director | 21-Feb-2006 | Current |
| Sanjay Garg | Director | 21-Feb-2006 | Current |
| Sonika Garg | Director | 23-May-2007 | Current |
Financial Performance of Ratan Medicos.
Ratan Medicos Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.5% increase. The company also saw a slight improvement in profitability, with a 5.93% increase in profit. The company's net worth Soared by an impressive increase of 17.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ratan Medicos?
In 2023, Ratan Medicos had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Greno Projects Private LimitedActive 11 years 2 months
Ravinder Garg and Sanjay Garg are mutual person
- Greno Infotech Private LimitedActive 8 years 3 months
Ravinder Garg and Sanjay Garg are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 25 Jul 2009 | ₹7.50 M | Open |
Allahabad Bank Creation Date: 30 Oct 2007 | ₹3.00 M | Open |
How Many Employees Work at Ratan Medicos?
Ratan Medicos has a workforce of 25 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ratan Medicos, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ratan Medicos's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
